Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-22-005518

10% owner bought 17,500 shares at an average $3.65 ($63,950)

From the SEC's structured data for this filing

Trades in this filing

Cambrian BioPharma Inc · 10% owner

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-02-23 Purchase : show line 1 in the form +2,500 $3.80 $9,500 5,210,786 D
2022-02-24 Purchase : show line 2 in the form +15,000 $3.63 $54,450 5,225,786 D
Open-market purchases · 17,500 sh · avg $3.65 · $63,950
Loading xslF345X03/doc1.xml…